TSS Welcomes Thomas Lindén as New Chief Technology Officer

TSS logo.
TSS, a leading temperature monitoring solutions provider, is pleased to announce the appointment of Thomas Lindén as its new Chief Technology Officer (CTO). In this role, Thomas Lindén will play a crucial part in shaping the company's technological landscape and driving its growth strategies.
PRESS RELEASE 12 September 2023

Thomas Lindén brings with him a wealth of experience and expertise. He holds a Master of Science degree in Systems, Control, and Robotics from the prestigious KTH Royal Institute of Technology. Recently serving as the Vice President of Engineering at Solidsport, a SaaS sports streaming platform, he has demonstrated exceptional leadership in guiding the company's technical endeavours.

His previous role at Solidsport involved overseeing the engineering division, where he played a pivotal role in preparing the technology organization for a successful European expansion. This endeavour encompassed a strategic focus on technical solutions, talent acquisition, process enhancement, and establishing effective routines. Furthermore, Thomas Lindén has served as Interim CEO of Solidsport, highlighting his multifaceted leadership capabilities.

Prior to his tenure at Solidsport, Thomas spent over a decade in the defense industry, contributing extensively to the development of safety-critical and mission-critical systems at Saab. He held key positions, leading software projects and eventually ascending to the role of Section Manager for Electronic Warfare software platform to Gripen E/F at first, and later on the Combat System software platform to naval ships, including e.g. the Visby-class Corvette and A26. Furthermore, he spearheaded the introduction of a collaborative software supply chain in collaboration with Ericsson, a testament to his prowess in driving strategic partnerships.

Commenting on his new role, Thomas Lindén expressed enthusiasm about contributing to TSS's strategic tech agenda. He emphasized the importance of cohesive teamwork as a fundamental pillar of success and looks forward to his new endeavours at TSS.

The Chief Executive Officer (CEO) of TSS, Dr. Niclas Ohlsson, lauded Thomas's impressive track record and visionary leadership. Dr. Niclas Ohlsson explained, "Thomas Lindén's remarkable journey in technology leadership, coupled with his strategic acumen, makes him the ideal choice to lead TSS's technological advancements. We are confident that his expertise will further propel TSS towards achieving our business goals."

TSS eagerly anticipates the innovative and transformative contributions that Thomas Lindén will bring to the company in his capacity as Chief Technology Officer. His appointment signals a new era of technological innovation and strategic growth for TSS.

Thomas Lindén, Chief Technology Officer, TSS
Thomas Lindén, Chief Technology Officer, TSS

About TSS

TSS is a temperature control monitoring and supply chain solutions provider serving the life science and pharmaceutical industry globally. With headquarters in Sweden, TSS have 30 years of experience providing a compliance baseline in hosting GxP Data and GxP validated SaaS to life science companies.

TSS aims to assure safe drugs for every patient by transforming the global pharmaceutical supply chain through an industry leading cloud temperature management solutions. Working in partnership with pharmaceutical companies, TSS provide advanced monitoring and analytics tools to help our client's meet compliance, implement lean and sustainable supply chains, and deliver drugs safely.

Contact

Niclas Ohlsson, PhD
Chief Executive Officer, TSS
niclas.ohlsson@tss.se

For media inquiries:

Josefin Malmgren
Head of Marketing, TSS
josefin.malmgren@tss.se

You may also be interested in

Reducing excursion evaluation time from days to seconds

The question of how to speed up clinical trials is complicated, especially considering that many trial stages simply cannot be rushed in the interest of trial subjects and the general public. However, process improvements can go a long way.
Read moreDownload Whitepaper
A large array of COVID-19 vaccine vials.

White paper: The next step to automating clinical trials

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.
Read moreDownload Whitepaper
People seated at round tables in a conference room watching a presenter speak in front of a large screen displaying a pie chart.

Working Together to Make Clinical Trials Faster and Safer

TSS recently hosted the TSS User Forum 2025, bringing together leading experts from the life science industry to discuss how automation, data integrity, and collaboration can make temperature management in clinical trials faster, safer, and more reliable.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.